Data / Drug companies / Doxycycline hyclate
Doxycycline hyclate: 61 companies and 186 products in the FDA NDC directory
Doxycycline hyclate is listed in the FDA National Drug Code Directory by 61 companies, with 186 products in commercial distribution. 180 of the products (96.8%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are capsule; tablet, film coated; tablet, and the newest product started marketing on June 22, 2026.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 61
- Products
- 186
- Generic (ANDA) products
- 180 (96.8%)
- Application numbers
- 37
- Routes
- Oral, Intravenous
- Brand names
- Doxycycline, Acticlate Cap, Doryx MPC, Targadox, Doxycyclate Hyclate
- openFDA record search
- api.fda.gov
Companies that list doxycycline hyclate
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| A-S Medication Solutions | 11 | capsule; tablet, film coated | Generic drugs (ANDA) | March 7, 2025 |
| Alembic Pharmaceuticals Inc. | 11 | tablet, film coated; tablet, delayed release | Generic drugs (ANDA) | January 4, 2022 |
| Alembic Pharmaceuticals Limited | 11 | tablet, film coated; tablet, delayed release | Generic drugs (ANDA) | January 4, 2022 |
| Bryant Ranch Prepack | 11 | capsule; tablet | Generic drugs (ANDA) | January 10, 2022 |
| Remedyrepack Inc. | 11 | capsule; tablet, film coated | Generic drugs (ANDA) | May 13, 2026 |
| Chartwell RX, LLC | 8 | tablet, film coated; capsule | Generic drugs (ANDA) | July 27, 2021 |
| NuCare Pharmaceuticals,Inc. | 8 | capsule; tablet, film coated | Generic drugs (ANDA) | October 9, 2019 |
| PD-Rx Pharmaceuticals, Inc. | 8 | tablet, film coated; capsule | Generic drugs (ANDA) | August 21, 2020 |
| Redpharm Drug | 5 | tablet; tablet, film coated | Generic drugs (ANDA) | March 7, 2025 |
| Ajanta Pharma USA Inc. | 4 | tablet; capsule | Generic drugs (ANDA) | June 1, 2020 |
| Chartwell Governmental & Specialty RX, LLC. | 4 | capsule; tablet, film coated | Generic drugs (ANDA) | July 21, 2021 |
| Heritage Pharmaceuticals Inc. D/B/A Avet Pharmaceuticals Inc. | 4 | tablet, delayed release | Generic drugs (ANDA) | March 16, 2018 |
| Proficient Rx LP | 4 | tablet; capsule | Generic drugs (ANDA) | January 10, 2022 |
| Proficient Rx LP | 4 | capsule; tablet, film coated | Generic drugs (ANDA) | July 10, 1986 |
| Sun Pharmaceutical Industries, Inc. | 4 | tablet, film coated; capsule | Generic drugs (ANDA) | May 13, 2005 |
| Actavis Pharma, Inc. | 3 | tablet, delayed release; tablet | Generic drugs (ANDA) | August 14, 2019 |
| Advanced Rx of Tennessee, LLC | 3 | capsule | Generic drugs (ANDA) | March 2, 2023 |
| Asclemed USA, Inc. | 3 | capsule | Generic drugs (ANDA) | January 10, 2022 |
| AvPAK | 3 | capsule; tablet, film coated | Generic drugs (ANDA) | June 4, 2014 |
| Bryant Ranch Prepack | 3 | tablet; capsule | Generic drugs (ANDA) | October 9, 2019 |
| Direct_Rx | 3 | capsule; tablet, film coated | Generic drugs (ANDA) | January 3, 2025 |
| Hikma Pharmaceuticals USA Inc. | 3 | capsule; tablet, coated | Generic drugs (ANDA) | July 2, 2003 |
| Solco Healthcare US, LLC | 3 | tablet, delayed release | Generic drugs (ANDA) | November 28, 2018 |
| Viona Pharmaceuticals Inc | 3 | capsule; tablet | Generic drugs (ANDA) | January 10, 2022 |
| Zydus Lifesciences Limited | 3 | capsule; tablet | Generic drugs (ANDA) | September 12, 2018 |
| Cardinal Health 107, LLC | 2 | tablet, coated | Generic drugs (ANDA) | March 22, 2013 |
| Coupler LLC | 2 | capsule | Generic drugs (ANDA) | May 26, 2026 |
| Epic Pharma, LLC | 2 | tablet; tablet, film coated | Generic drugs (ANDA) | March 7, 2025 |
| Health Department, Oklahoma State | 2 | capsule; tablet, film coated | Generic drugs (ANDA) | March 7, 2025 |
| Macleods Pharmaceuticals Limited | 2 | capsule; tablet | Generic drugs (ANDA) | December 9, 2025 |
| Major Pharmaceuticals | 2 | tablet, coated; capsule | Generic drugs (ANDA) | August 5, 2008 |
| Northwind Health Company, LLC | 2 | capsule; tablet, coated | Generic drugs (ANDA) | February 27, 2023 |
| PD-Rx Pharmaceuticals, Inc. | 2 | capsule | Generic drugs (ANDA) | May 7, 1984 |
| Slate Run Pharmaceuticals, LLC | 2 | powder, for solution | Generic drugs (ANDA) | July 22, 2024 |
| Sportpharm LLC | 2 | capsule | Generic drugs (ANDA) | January 10, 2022 |
| Strides Pharma Science Limited | 2 | tablet | Generic drugs (ANDA) | May 14, 2026 |
| Zhejiang Yongtai Pharmaceutical Co., Ltd | 2 | capsule | Generic drugs (ANDA) | February 1, 2026 |
| Acella Pharmaceuticals, LLC | 1 | tablet, coated | Generic drugs (ANDA) | August 21, 2020 |
| Almirall, LLC | 1 | capsule | New drug applications (NDA) | May 31, 2018 |
| American Health Packaging | 1 | tablet, coated | Generic drugs (ANDA) | March 8, 2013 |
| American Health Packaging | 1 | capsule | Generic drugs (ANDA) | April 17, 2020 |
| Cranbury Pharmaceuticals, LLC | 1 | tablet | Generic drugs (ANDA) | October 9, 2019 |
| Direct RX | 1 | capsule | Generic drugs (ANDA) | January 1, 2014 |
| Golden State Medical Supply, Inc. | 1 | tablet, film coated | Generic drugs (ANDA) | September 11, 1984 |
| Hawaii Repack, Inc. | 1 | capsule | Generic drugs (ANDA) | September 11, 1984 |
| Hikma Pharmaceuticals | 1 | capsule | Generic drugs (ANDA) | September 1, 1990 |
| JG Pharma Inc. | 1 | tablet, film coated | Generic drugs (ANDA) | August 1, 2025 |
| Journey Medical Corporation | 1 | tablet | Generic drugs (ANDA) | August 29, 2016 |
| Larken Laboratories, Inc. | 1 | tablet | Generic drugs (ANDA) | November 15, 2010 |
| Lupin Pharmaceuticals,Inc. | 1 | tablet | Generic drugs (ANDA) | September 6, 2017 |
| Mayne Pharma | 1 | tablet, delayed release | Authorized generics (NDA) | February 1, 2016 |
| Mayne Pharma Inc. | 1 | tablet, delayed release | New drug applications (NDA) | January 2, 2023 |
| NCS HealthCare of Ky, LLC DBA Vangard Labs | 1 | tablet | Generic drugs (ANDA) | March 14, 2019 |
| Novel Laboratories, Inc. | 1 | tablet | Generic drugs (ANDA) | September 6, 2017 |
| PD-Rx Pharmaceuticals, Inc. | 1 | tablet, coated | Generic drugs (ANDA) | July 2, 2003 |
| Puracap Laboratories LLC DBA Blu Pharmaceuticals | 1 | tablet, film coated | Generic drugs (ANDA) | March 7, 2025 |
| QPharma, Inc. | 1 | tablet, coated | Generic drugs (ANDA) | July 2, 2003 |
| Quality Care Products LLC | 1 | capsule | Generic drugs (ANDA) | April 16, 2012 |
| Sonoma Pharmaceuticals, Inc. | 1 | tablet, delayed release | Generic drugs (ANDA) | November 28, 2016 |
| St. Mary's Medical Park Pharmacy | 1 | tablet | Generic drugs (ANDA) | August 17, 2023 |
| Unit Dose Solutions, Inc. | 1 | capsule | Generic drugs (ANDA) | June 22, 2026 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Capsule | 77 | 41.4% |
| Tablet, film coated | 43 | 23.1% |
| Tablet | 31 | 16.7% |
| Tablet, delayed release | 20 | 10.8% |
| Tablet, coated | 13 | 7% |
| Powder, for solution | 2 | 1.1% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 180 | 96.8% |
| Authorized generics (NDA) | 4 | 2.2% |
| New drug applications (NDA) | 2 | 1.1% |
Pharmacologic classes
| Class | Products |
|---|---|
| Tetracycline-class Drug | 186 |
Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.